Vijay Chiruvolu is Vice President at Kite Pharma, a Gilead Sciences company, and leads the Process Development organization. The Process Development group at Kite is responsible for process design of autologous, allogeneic, neoantigen and vector products, analytical development, tech transfer, validation, comparability, technology development, and Manufacturing Science & Technology (MSAT functions.
Vijay joined Kite in Sept 2014, and since that time he has built a strong team dedicated to process and product understanding, clinical and commercial manufacturing...Read more
